PARAS HEALTHCARE LIMITED

21 Oct 2026 - 23 Oct 2026 Main Board BSE NSE

Min Investment

₹14,553.00

Price Band

₹660-₹693

Issue Size

₹837.37 Cr

Lot Size

21 (per lot)

IPO Dates
img

21 Oct 2026

Open Date

img

23 Oct 2026

Close Date

img

26 Oct 2026

Allotment Date

img

28 Oct 2026

Listing Date

Know Before Investing

Strengths icon

  • Established “Paras Health” brand in underserved North and East India markets.
  • High revenue reliance on specialized CONGOR clinical programs.
  • Diversified network of eight multi-specialty hospitals with 2
  • 211 beds.
  • Advanced quaternary care supported by modern medical infrastructure.
  • Improved occupancy rates and a turnaround to profitability in Fiscal 2026.

Weaknesses icon

  • High medical staff attrition may impact care quality.
  • High revenue concentration in North India poses regional risks.
  • Over-reliance on CONGOR specialties risks revenue drops.
  • High debt of ₹9
  • 394.67 million strains cash flows.
  • Unregistered hospital leases risk eviction and disruption.

About Paras Healthcare Limited

Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.

IPO Objectives

1. Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by our Company

2. Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL

3. General corporate purposes

Company Promoters

Dharminder Kumar Nagar

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 3.09
Non-Institutional Buyers 0.66
Retail Investors 2
Total 5.75
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account